The purpose of this study is to understand why there are differences in outcomes in adolescents and young adults treated for Acute Lymphoblastic Leukemia.
If you decide to take part in this study you will be asked to refill your regular doses of 6-mercaptopurine (6MP) and methotrexate (MTX) in a special MEMS® medication bottle with TrackCap™. This cap and bottle system will help the study team to track when the medication bottle is opened. You will be asked to fill out a questionnaire at the beginning and end of the study. A small amount of blood will be collected along with your regular blood draws.
Clinical or Medical
Cancer (Pediatric Cancers, Leukemia)
Child and Teen Health